| Cynomolgus CD300A Protein (LTP10026) |
| LTP10026 |
| 100ug |
|
$473 In stock |
| CD300a is an inhibitory receptor for mast cells and eosinophils in allergic inflammation (AI); however, the spatiotemporal expression of CD300a and its potential roles in the resolution of AI are still to be determined.CD300a expression on peritoneal cells is regulated from inflammation to resolution. CD300a activation on mouse bone marrow-derived mast cells regulated ALX/FPR2 expression levels following IgE-mediated activation. |
| Recombinant Cynomolgus CD300A Protein is expressed from Expi293 with His tag at the C-terminal. It contains Leu18-Gln178. |
| CD300A |
| Cynomolgus |
| A0A7N9CE79 |
| Leu18-Gln178 |
| The protein has a predicted MW of 18.73 kDa. Due to glycosylation, the protein migrates to 45-50 kDa based on the Tris-Bis PAGE result. |
| 0 |
| C-His |
| Expi293 |
| > 95% as determined by Tris-Bis PAGE; > 95% as determined by HPLC |
| Less than 1EU per ug by the LAL method. |
| Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as a protectant before lyophilization. |
| Reconstituted protein stable at -80 C for 12 months, 4 C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
| Shipped at ambient temperature. |
| Centrifuge tubes before opening. Reconstituting to a concentration of more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water. |
|  |
|  |